E-LIB Suche - Ergebnisse für: Hou, I-Cheng

1

Analyzing risk factors and developing a stratification syst..:

Luan, Chih-Hsuan ; Su, Pin-Shuo ; Chu, Chi-Jen...
Journal of the Chinese Medical Association. 87 (2024) 4 - p. 357-368 , 2024

Link: https://doi.org/10.1097/..

2

THU-479 The features of gut microbiota and metabolites in n..:

Lee, Pei-Chang ; Hung, Ya-Wen ; Wu, Chi-Jung...
Journal of Hepatology. 80 (2024) - p. S449 , 2024

Link: https://doi.org/10.1016/..

3

Using flow cytometry to develop a competitive assay for the..:

Lin, Wei-Ting ; How, Su-Chun ; Lin, Wen-Zhi...
Journal of the Taiwan Institute of Chemical Engineers. 143 (2023) - p. 104691 , 2023

Link: https://doi.org/10.1016/..

4

Impact of direct-acting antiviral therapy on tumor progress..:

Chi, Chen-Ta ; Lee, I-Cheng ; Lan, Keng-Hsin...
Journal of Hepatology. 78 (2023) - p. S1172-S1173 , 2023

Link: https://doi.org/10.1016/..

5

A novel AFP-M2BPGi score has better performance than CRAFIT..:

Lee, Pei-Chang ; Wu, Chijung ; Huang, Kuo-Wei...
Journal of Hepatology. 78 (2023) - p. S496-S497 , 2023

Link: https://doi.org/10.1016/..

6

Radiologic Patterns Determine the Outcomes of Initial and S..:

Hung, Ya-Wen ; Lee, I-Cheng ; Chi, Chen-Ta...
Liver Cancer. 13 (2023) 1 - p. 29-40 , 2023

Link: https://doi.org/10.1159/..

7

Outcomes of patients with malignant esophagogastric junctio..:

Pan, Yu-Ling ; Wu, Pei-Shan ; Ye, Bing-Wei...
Journal of the Chinese Medical Association. 85 (2022) 2 - p. 160-166 , 2022

Link: https://doi.org/10.1097/..

8

Lenvatinib plus pembrolizumab for systemic therapy-naïve an..:

Wu, Chi-Jung ; Lee, Pei-Chang ; Hung, Ya-Wen...
Cancer Immunology, Immunotherapy. 71 (2022) 11 - p. 2631-2643 , 2022

Link: https://doi.org/10.1007/..

9

Application and Impact of Antiviral Therapy for Patients wi..:

Lee, I-Cheng ; Lee, Pei-Chang ; Chao, Yee...
Viruses. 14 (2022) 11 - p. 2355 , 2022

Link: https://doi.org/10.3390/..

10

Determinants of Survival and Post-Progression Outcomes by S..:

Lee, I-Cheng ; Chao, Yee ; Lee, Pei-Chang...
Cancers. 14 (2022) 8 - p. 2014 , 2022

Link: https://doi.org/10.3390/..

11

Durable objective response to sorafenib and role of sequent..:

Huang, Kuo-Wei ; Lee, Pei-Chang ; Chao, Yee...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592210994 , 2022

Link: https://doi.org/10.1177/..

12

A preferable signature of gut microbiota and bile acids pre..:

Lee, Pei-Chang ; Wu, Chijung ; Hung, Ya-Wen...
Journal of Hepatology. 77 (2022) - p. S109-S110 , 2022

Link: https://doi.org/10.1016/..

13

Outcome predictors of gemcitabine-based or fluoropyrimidine..:

Chi, Chen-Ta ; Lee, I-Cheng ; Chen, Ming-Huang...
Journal of Hepatology. 77 (2022) - p. S375 , 2022

Link: https://doi.org/10.1016/..

14

Gut microbiota and metabolites associate with outcomes of i..:

Lee, Pei-Chang ; Wu, Chi-Jung ; Hung, Ya-Wen...
Journal for ImmunoTherapy of Cancer. 10 (2022) 6 - p. e004779 , 2022

Link: https://doi.org/10.1136/..

15

Efficacy and Renal Safety of Prophylactic Tenofovir Alafena..:

Lee, I-Cheng ; Lan, Keng-Hsin ; Su, Chien-Wei...
International Journal of Molecular Sciences. 23 (2022) 19 - p. 11335 , 2022

Link: https://doi.org/10.3390/..